References
- Yamakawa K, Kigosi S, Muramatu I. The selectivity of DG-5128 as alpha-2 adrenoceptor antagonist. Eur J Pharmacol 1985; 106: 625, 628
- Kameda K, Kyama I, Abiko Y. Comparative study on the effects of hypoglycemic 2-substituted-2-imidazoline derivative (DG-5128) and tolubutamide on insulin secretion from and insulin synthesis in the isolated rat pancreatic islets. Biochem Biophys Acta 1981; 677: 263, 268
- Kameda K, Ono S, Koyama I, Abiko Y. Insulin releasing action of 2-[2-(4,5-dihydro-lH-imidazol-2-yl) -1-phenylethyl] pyridine dihydrochloride ses-quihydrate (DG-5128), a new, orally effective hypoglycemic agent. Acta Endocrinol 1982; 99: 410, 415
- Ono S, Hara T, Tomikawa M. Effect of midaglizole, an alpha-2-adrenoceptor antagonist, on insulin release and platelet aggregation. Recent Trends in Management of Diabetica Mellitus. Elsevier Science Publishers, New York 1987; 312–315
- Yoshie Y, Lizuka K, Nakazawa T. The inhibitory effect of a selective alpha-2 adrenoceptor antagonist on moderate- to severe-type asthmatics. J Allergy Clin Immunol 1989; 84: 141, 152
- Nakaoka M, Ohtani A, Hakusui H. Quantitation of a new hypoglycemic drug, 2-[(4,5-dihydro-lH-imadazol-2-yiyi-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128), in plasma by gas chromatography mass spectrometry. J Chromatogr 1986; 387: 467, 472
- Black J, Salome C, Van K, Shaw J. The action of prazosin and propylene glycol on methoxamine-induced bronchoconstriction in asthmatic subjects. Br J Clin Pharmacol 1984; 18: 349, 353
- Beil M, deKock M A. Role of alpha-adrenergic receptors in exercise-induced bronchoconstriction. Respiration 1978; 35: 78, 86
- Patel K R., Kerr J W. Effect of alpha receptor blocking drug, thymoxamine, on allergen induced bronchoconstriction in extrinsic asthma. Clin Allergy 1975; 5: 311, 316
- Sly R M., Heimlich E M., Busser R J., Strick L. Exercise-induced bronchospasm: effect of adrenergic and cholinergic blockade. J Allergy 1967; 40: 93, 99
- Utting J A. Alpha-adrenergic blockade in severe asthma. Br J Dis Chest 1979; 73: 317, 318
- Dyson A J., Hills E A., Mackay A D., Wood J B. Is in-doramine useful in the treatment of asthma?. Br J Dis Chest 1980; 74: 403, 404
- Walden S M., Bleecker E R., Chahal K, Britt E J., Mason P, Permutt S. Effect of alpha-adrenergic blockade on exercise-induced asthma and conditioned cold air. Am Rev Respir Dis 1984; 130: 357, 362
- Gross G N., Souhrada J F., Farr R S. The longterm treatment of an asthmatic patient using phen-tolamine. Chest 1974; 66: 397, 401
- Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 1981; 58: 199, 236
- Lizuka K, Yoshie Y, Matui S, Umegae Y, Fueki R, Kobayashi S, Nakazawa T. Investigation of the beta-adrenergic dysfunction on hormone-sensitive adenylate cyclase system in asthmatic lymphocyte cell membranes. Jap J Allergol 1987; 36: 909, 916
- Yoshie Y, Lizuka K, Umegae Y, Kobayashi S, Nakazawa T. Inhibitory effect of an alpha-2 adrenoceptor antagonist (DG-5128) on intractable asthma. Jap J Allergol 1987; 36: 413, 116
- Yoshie Y, Lizuka K, Nakazawa T. Inhibitory effect of DG-5128 on steroid-dependent asthma. J Asthma 1988; 25: 321, 324